• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / VATS Vagotomy for the treatment of Chronic Marginal Ulcer

VATS Vagotomy for the treatment of Chronic Marginal Ulcer

Background:
Gastric Bypass is an increasingly common procedure. Associated rare complications have a related increased occurrence. Marginal ulceration at the gastrojejunal anastomosis has a reported incidence of 5 to 12%. In most instances these ulcers can be managed conservatively using acid suppression with proton pump inhibitors and sucralfate. There is a troublesome subset of this population, resistant to conservative measures. They are the patients with chronic epigastric pain and persistent marginal ulcerations. These patients find themselves at an increased risk for significant complications of bleeding and perforation at the ulcer site. It is possible that this subset likely has remnant parietal cells in the gastric pouch. If parietal cells remain innervated by vagal fibers, intuitively there will be persistently elevated levels of acid across the gastrojejunal anastomosis amendable to suppression by vagotomy. This study reviews our experience with video assisted thoracoscopy vagotomy as an option in the treatment of persistent marginal ulcers after gastric bypass.
Methods:
A retrospective analysis of 11 patients was performed by means of chart review and phone interviews. All patients had Laparoscopic Roux-en-Y Gastric Bypass performed in similar fashion by the same group of surgeons after EGD evidence of marginal ulceration resistant to medical management. These patients underwent vagotomy by a single surgeon over a one-year period. Access was via four to five 5mm chest ports and involved division and clipping of both branches of the vagus nerve at the level of the distal esophagus. After chart review, patients were contacted by phone and interviewed about their current related symptoms and medications.
Results:
Eleven patients underwent VATS vagotomy for chronic marginal ulceration. The average original BMI was 52.8 (45.7-62.1). Average weight loss 146.5 lb (84-244). Average post VATS follow-up 6 mo (1-12). Average EGD performed after VATS was 4. Ulcer resolution occurred in 8 of the 11 patients. Five of 11 had gastrojejunal anastomosis revision with subsequent ulceration prior to VATS. Two patients required gastrojejunal anastomotic revision after VATS vagotomy. Eight patients had improvement in their associated pain and symptoms. There were no complications related to the VATS procedure.
Conclusion:
VATS vagotomy is a useful tool in the treatment of the complicated post gastric bypass patient with chronic marginal ulceration. 73% of our study population had resolution of ulceration and 73% had improvement in associated symptoms. Further investigation will be helpful in delineating the details of this unique approach to a difficult condition.


Session: Poster

Program Number: P014

View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search